Evidence map›Paper›PMID 18815832›Full record

ArticleCurrent microbiology2008

The lysis system of the Streptomyces aureofaciens phage mu1/6.

Jarmila Farkasovská, Andrej Godány

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jarmila FarkasovskáInstitute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia. jarmila.farkasovska@savba.sk
Andrej Godány
Slovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, two genes, designated as lyt and hol, were identified in the lysis module of phage mu1/6. They were cloned and expressed in Escherichia coli. An additional candidate holin gene, hol2, was found downstream from the hol gene based on one predicted transmembrane domain and a highly charged C-terminal sequence of the encoded protein. Expression of hol or hol2 in E. coli was shown to cause cell death. The concomitant expression of lambda endolysin (R) and mu1/6 holin resulted in cell lysis. Similarly, the coexpression of the endolysin and holin of phage mu1/6 led to lysis, apparently due to the ability of mu1/6 endolysin to hydrolyze the peptidoglycan layer of this bacterium. In contrast, the simultaneous expression of mu1/6 hol2 and the endolysin gene (lambdaR or mu1/6 lyt) did not cause detectable lysis of the host cells. Demonstration of the holin function in streptomycetes was achieved by providing for the release of mu1/6 endolysin to the periplasm and subsequent cleavage of the peptidoglycan, which strongly suggested that the holin produces lesions in the streptomycete membrane.

Indexed as

BacteriolysisAmino Acid SequenceBacteriophagesCloning, MolecularEndopeptidasesEscherichia coliGene ExpressionMicrobial Sensitivity TestsMicrobial ViabilityMolecular Sequence DataPeptidoglycanStreptomyces aureofaciensViral ProteinsendolysinEndopeptidasesPeptidoglycanViral Proteins

Identifiers

PMID18815832
OpenAlexW2005190114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.